Business
Medlab Clinical Ltd (ASX: MDC) is pleased to announce the NanoCBD™ update. Medlab’s NanoCBD™ product has been developed out of our US operations, with manufacturing underway at a licenced FDA facility, and has already received its first export order and deposit for 1,500 units to Hong Kong.